Sprycel (dasatinib) is a cancer medicine that slows the growth and spread of cancer cells in the body.
Sprycel is used in adults and children to treat a type of blood cancer called Philadelphia chromosome-positive chronic myelogenous leukemia (CML).
Sprycel is also used to treat Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) in adults and children.
